Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
EVKG Ever-Glory International Group	$0.00	$0.00	$0.00 ▼ $0.01	$10K	3.84	12,874 shs	N/A
LULU lululemon athletica	$193.33 -3.6%	$248.66	$191.44 ▼ $423.32	$24.03B	1.17	2.88 million shs	4.68 million shs
ONON ON	$47.08 -3.1%	$53.86	$34.59 ▼ $64.05	$30.58B	2.24	4.39 million shs	8.75 million shs
SILO Silo Pharma	$0.73 -6.8%	$0.60	$0.41 ▼ $3.37	$3.49M	0.29	679,231 shs	311,562 shs

10 Stocks Set to Soar in Summer 2025

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
EVKG Ever-Glory International Group	0.00%	0.00%	0.00%	0.00%	0.00%
LULU lululemon athletica	-3.59%	-11.89%	-21.51%	-30.30%	-25.26%
ONON ON	-3.10%	-7.26%	-12.36%	-3.64%	+13.64%
SILO Silo Pharma	-6.80%	+8.97%	+15.42%	-3.19%	-64.75%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
EVKG Ever-Glory International Group	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
LULU lululemon athletica	4.7483 of 5 stars	4.3	5.0	0.0	1.7	1.4	2.5	2.5
ONON ON	4.1776 of 5 stars	4.5	3.0	0.0	0.0	4.0	1.7	1.9
SILO Silo Pharma	0.8687 of 5 stars	0.0	5.0	0.0	0.0	0.0	1.7	0.6

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
EVKG Ever-Glory International Group	0.00	N/A	N/A	N/A
LULU lululemon athletica	2.55	Moderate Buy	$331.80	71.63% Upside
ONON ON	2.95	Moderate Buy	$64.00	35.94% Upside
SILO Silo Pharma	0.00	N/A	N/A	N/A

Current Analyst Ratings Breakdown

Latest SILO, EVKG, ONON, and LULU Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
7/29/2025	LULU lululemon athletica	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Neutral ➝ Neutral	$270.00 ➝ $200.00
7/22/2025	LULU lululemon athletica	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Overweight ➝ Neutral	$303.00 ➝ $224.00
7/22/2025	ONON ON	Raymond James Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Strong-Buy ➝ Outperform	$66.00
6/9/2025	LULU lululemon athletica	CICC Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform ➝ Market Perform	$280.49
6/9/2025	LULU lululemon athletica	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Equal Weight ➝ Equal Weight	$276.00 ➝ $270.00
6/9/2025	LULU lululemon athletica	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Equal Weight	$346.00 ➝ $280.00
6/6/2025	LULU lululemon athletica	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Equal Weight ➝ Equal Weight
6/6/2025	LULU lululemon athletica	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Equal Weight ➝ Equal Weight
6/6/2025	LULU lululemon athletica	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Market Perform ➝ Market Perform	$302.00 ➝ $250.00
6/6/2025	LULU lululemon athletica	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$400.00 ➝ $370.00
6/6/2025	LULU lululemon athletica	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Neutral ➝ Neutral	$325.00 ➝ $270.00

(Data available from 8/2/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
EVKG Ever-Glory International Group	N/A	N/A	N/A	N/A	N/A	N/A
LULU lululemon athletica	$10.59B	2.19	$17.97 per share	10.76	$35.65 per share	5.42
ONON ON	$2.63B	11.26	$0.56 per share	83.89	$2.51 per share	18.76
SILO Silo Pharma	$72.10K	45.16	N/A	N/A	$1.12 per share	0.65

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
EVKG Ever-Glory International Group	N/A	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A
LULU lululemon athletica	$1.81B	$14.76	13.10	12.57	1.71	16.82%	43.48%	25.05%	8/27/2025 (Estimated)
ONON ON	$275.23M	$0.70	67.26	54.74	2.73	7.81%	14.79%	8.83%	8/12/2025 (Estimated)
SILO Silo Pharma	-$4.39M	-$1.17	N/A	∞	N/A	-6,420.83%	-84.88%	-61.81%	8/12/2025 (Estimated)

Latest SILO, EVKG, ONON, and LULU Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/12/2025	Q2 2025	ONON ON	$0.24	N/A	N/A	N/A	$707.74 million	N/A
6/5/2025	Q1 2026	LULU lululemon athletica	$2.60	$2.60	N/A	$2.60	$2.36 billion	$2.37 billion
5/9/2025	Q1 2025	SILO Silo Pharma	N/A	-$0.23	N/A	-$0.23	N/A	$0.02 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
EVKG Ever-Glory International Group	N/A	N/A	N/A	N/A	N/A
LULU lululemon athletica	N/A	N/A	N/A	N/A	N/A
ONON ON	N/A	N/A	N/A	N/A	N/A
SILO Silo Pharma	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
EVKG Ever-Glory International Group	N/A	N/A	N/A
LULU lululemon athletica	N/A	2.28	1.23
ONON ON	0.19	2.80	2.18
SILO Silo Pharma	N/A	4.73	4.73

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
EVKG Ever-Glory International Group	N/A
LULU lululemon athletica	85.20%
ONON ON	36.39%
SILO Silo Pharma	5.58%

Insider Ownership

Company	Insider Ownership
EVKG Ever-Glory International Group	35.53%
LULU lululemon athletica	0.54%
ONON ON	68.57%
SILO Silo Pharma	4.37%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
EVKG Ever-Glory International Group	4,300	14.66 million	N/A	Not Optionable
LULU lululemon athletica	39,000	119.85 million	119.20 million	Optionable
ONON ON	3,254	629.65 million	197.90 million	Optionable
SILO Silo Pharma	2	4.48 million	4.29 million	Not Optionable

SILO, EVKG, ONON, and LULU Headlines

Recent News About These Companies

Silo Pharma Announces Completion of Dosing in Safety Study of PTSD Drug SPC-15

July 16, 2025 | globenewswire.com

Silo Pharma Secures Exclusive License for CNS Peptides

July 10, 2025 | tipranks.com

Silo Pharma, Inc. Plans IND Application Submission for PTSD Drug SPC-15 with Potential Phase 1 Trial in 2026 - Nasdaq

July 9, 2025 | nasdaq.com

Silo Pharma, Inc. Plans IND Application Submission for PTSD Drug SPC-15 with Potential Phase 1 Trial in 2026

July 7, 2025 | quiverquant.comQ

Silo Pharma Advances PTSD Drug SPC-15 Toward Planned 2025 IND Submission with Pre-Clinical Study Data Expected in Q3 2025

July 7, 2025 | globenewswire.com

Silo Pharma Faces Nasdaq Non-Compliance Notice

July 3, 2025 | msn.com

Silo Pharma and Hoth Therapeutics plan joint venture for obesity treatment

June 26, 2025 | investing.com

Silo Pharma and Hoth Therapeutics to Form Joint Venture for VA-Developed Obesity Treatment - Nasdaq

June 26, 2025 | nasdaq.com

Silo Pharma Enters into Letter of Intent to Form Joint Venture with Hoth Therapeutics to Develop Obesity Treatment Targeting $16 Billion Global Market - Morningstar

June 26, 2025 | morningstar.comM

Silo Pharma Enters LOI for Joint Venture with Hoth Therapeutics to Develop Obesity Treatment Targeting $16 Billion Global Market

June 26, 2025 | jcnnewswire.comJ

Silo Pharma Enters into Letter of Intent to Form Joint Venture with Hoth Therapeutics to Develop Obesity Treatment Targeting $16 Billion Global Market

June 25, 2025 | globenewswire.com

Hoth Therapeutics (HOTH) and Silo Pharma (NASDAQ: SILO) today announced the formation of a 50/50 joint venture to develop a first-in-class GDNF-based therapy licensed from the U.S. Department of Veterans Affairs. The therapy targets obesity and fatty liver disease.

June 25, 2025 | prnewswire.com

Silo Pharma, Inc.: Silo Pharma Secures Biomarker Patent for Novel PTSD Therapeutic SPC-15 as Clinical Trial Nears

June 11, 2025 | finanznachrichten.de

Silo Pharma, Inc. Receives Notice of Allowance for Patent Strengthening SPC-15 Treatment for PTSD

June 11, 2025 | quiverquant.comQ

Silo Pharma Secures Biomarker Patent for Novel PTSD Therapeutic SPC-15 as Clinical Trial Nears

June 11, 2025 | globenewswire.com

16 Companies Announced A Bitcoin Treasury Last Week: Report

June 9, 2025 | coingape.comC

Silo Pharma, Inc. Approves $1 Million Bitcoin Purchase as Treasury Reserve Asset

June 7, 2025 | nasdaq.com

Silo Pharma Board of Directors Approves Purchase of Bitcoin as Treasury Reserve Asset

June 5, 2025 | globenewswire.com

Silo Wellness to Relist as Born Defense, a National Security Investment Issuer Focused on Ending Forever Wars and Upholding the Just War Doctrine

June 2, 2025 | newsfilecorp.comN

Silo Pharma, Inc.: Silo Pharma Partners with Resyca for IND-Supporting Intranasal Drug-Device Study of PTSD Drug SPC-15

May 23, 2025 | finanznachrichten.de

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

3 Defense Leaders Set to Gain From Rising Military Spend
By Chris Markoch | July 5, 2025
View 3 Defense Leaders Set to Gain From Rising Military Spend
3 Short Squeeze Candidates With Big Catalysts on the Horizon
By Dan Schmidt | July 25, 2025
View 3 Short Squeeze Candidates With Big Catalysts on the Horizon
2025: A Pivotal Year for Smart Glasses As Meta Invests in Ray-Ban
By Leo Miller | July 18, 2025
View 2025: A Pivotal Year for Smart Glasses As Meta Invests in Ray-Ban
Higher Consumer Confidence Could Benefit These 3 Retail Stocks
By Gabriel Osorio-Mazilli | July 31, 2025
View Higher Consumer Confidence Could Benefit These 3 Retail Stocks
On Holding: The Athleisure Stock Analysts Say Could Jump 40%
By Gabriel Osorio-Mazilli | July 8, 2025
View On Holding: The Athleisure Stock Analysts Say Could Jump 40%

SILO, EVKG, ONON, and LULU Company Descriptions

Ever-Glory International Group NASDAQ:EVKG

$0.0007 0.00 (0.00%)

As of 07/25/2025

Ever-Glory International Group, Inc., together with its subsidiaries, manufactures, supplies, and retails apparel in Mainland China, Hong Kong, Germany, the United Kingdom, Europe, Japan, and the United States. It operates through two segments, Wholesale and Retail. The company primarily offers casual wear, outerwear, and sportswear. Its products include coats, jackets, slacks, skirts, shirts, trousers, and jeans for women; vests, jackets, trousers, skiwear, shirts, coats, and jeans for men; and coats, vests, down jackets, trousers, knitwear, and jeans for children. The company offers its woman apparel under the La go go, Velwin, Sea To Sky, Jizhu, and idole brands. It also engages in the import and export of apparel, fabric, and accessories. The company provides its products directly to consumers through retail stores, as well as online stores at Tmall, Dangdang mall, JD.com, VIP.com, etc. As of March 31, 2022, it operated 848 stores in China. The company is based in Nanjing, the Peoples Republic of China.

lululemon athletica NASDAQ:LULU

$193.33 -7.20 (-3.59%)

Closing price 08/1/2025 04:00 PM Eastern

Extended Trading

$193.24 -0.09 (-0.05%)

As of 08/1/2025 07:59 PM Eastern

Lululemon Athletica Inc., together with its subsidiaries, designs, distributes, and retails athletic apparel, footwear, and accessories under the lululemon brand for women and men. It offers pants, shorts, tops, and jackets for healthy lifestyle, such as yoga, running, training, and other activities. It also provides fitness-inspired accessories. The company sells its products through a chain of company-operated stores; outlets; interactive workout platform; yoga and fitness studios, university campus retailers, and other partners; license and supply arrangements; and temporary locations, as well as through mobile apps and lululemon.com e-commerce website. It has operations in the United States, Canada, Mainland China, Australia, South Korea, Hong Kong, Japan, New Zealand, Taiwan, Singapore, Malaysia, Macau, Thailand, the Asia Pacific, the United Kingdom, Germany, France, Ireland, Spain, the Netherlands, Sweden, Norway, Switzerland, Europe, the Middle East, and Africa. Lululemon Athletica Inc. was founded in 1998 and is based in Vancouver, Canada.

ON NYSE:ONON

$47.08 -1.49 (-3.07%)

Closing price 08/1/2025 03:59 PM Eastern

Extended Trading

$47.13 +0.05 (+0.11%)

As of 08/1/2025 07:56 PM Eastern

On Holding AG engages in the development and distribution of sports products such as footwear, apparel, and accessories for high-performance running, outdoor, all-day activities, and tennis. It sells its products worldwide through independent retailers and global distributors, its own online presence, and its own stores. The company was founded by David Allemann, Olivier Bernhard, and Caspar Coppetti in January 2010 and is headquartered in Zurich, Switzerland.

Silo Pharma NASDAQ:SILO

$0.73 -0.05 (-6.80%)

Closing price 08/1/2025 04:00 PM Eastern

Extended Trading

$0.74 +0.01 (+1.50%)

As of 08/1/2025 07:57 PM Eastern

Silo Pharma Inc. operates as a developmental stage biopharmaceutical company. The company is developing therapeutics that address underserved conditions, including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in formulations and drug delivery systems. The company's lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders. It is also developing SP-26, a time-release ketamine-loaded implant for fibromyalgia and chronic pain relief. In addition, the company's two preclinical programs comprise SPC-14, an intranasal compound for the treatment of Alzheimer's disease, and SPU-16, a CNS-homing peptide targeting multiple sclerosis (MS). The company's research and development programs are conducted through collaborations with Columbia University and the University of Maryland, Baltimore. The company was formerly known as Uppercut Brands, Inc. and changed its name to Silo Pharma, Inc. in September 2020. Silo Pharma, Inc. was incorporated in 2010 and is based in Sarasota, Florida.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time